Year |
Citation |
Score |
2024 |
Ho WK, Hassan NT, Yoon SY, Yang X, Lim JMC, Binte Ishak ND, Ho PJ, Wijaya EA, Ng PP, Luccarini C, Allen J, Tai MC, Chiang J, Zhang Z, See MH, et al. Age-specific breast and ovarian cancer risks associated with germline or pathogenic variants - an Asian study of 572 families. The Lancet Regional Health. Western Pacific. 44: 101017. PMID 38333895 DOI: 10.1016/j.lanwpc.2024.101017 |
0.496 |
|
2023 |
Wilcox N, Dumont M, González-Neira A, Carvalho S, Joly Beauparlant C, Crotti M, Luccarini C, Soucy P, Dubois S, Nuñez-Torres R, Pita G, Gardner EJ, Dennis J, Alonso MR, Álvarez N, et al. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nature Genetics. PMID 37752376 DOI: 10.1038/s41588-023-01549-x |
0.561 |
|
2023 |
Wilcox N, Dumont M, González-Neira A, Carvalho S, Joly Beauparlant C, Crotti M, Luccarini C, Soucy P, Dubois S, Nuñez-Torres R, Pita G, Gardner EJ, Dennis J, Alonso MR, Álvarez N, et al. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nature Genetics. PMID 37592023 DOI: 10.1038/s41588-023-01466-z |
0.559 |
|
2023 |
Jandu HK, Veal CD, Fachal L, Luccarini C, Aguado-Barrera ME, Altabas M, Azria D, Baten A, Bourgier C, Bultijnck R, Colciago RR, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, et al. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109806. PMID 37437607 DOI: 10.1016/j.radonc.2023.109806 |
0.549 |
|
2022 |
Li S, MacInnis RJ, Lee A, Nguyen-Dumont T, Dorling L, Carvalho S, Dite GS, Shah M, Luccarini C, Wang Q, Milne RL, Jenkins MA, Giles GG, Dunning AM, Pharoah PDP, et al. Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. American Journal of Human Genetics. 109: 1777-1788. PMID 36206742 DOI: 10.1016/j.ajhg.2022.09.006 |
0.455 |
|
2022 |
Dumont M, Weber-Lassalle N, Joly-Beauparlant C, Ernst C, Droit A, Feng BJ, Dubois S, Collin-Deschesnes AC, Soucy P, Vallée M, Fournier F, Lemaçon A, Adank MA, Allen J, Altmüller J, ... ... Luccarini C, et al. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry. Cancers. 14. PMID 35884425 DOI: 10.3390/cancers14143363 |
0.536 |
|
2022 |
Ahearn TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, Awuah B, Yarney J, Edusei L, Titiloye N, Adjei E, Vanderpuye V, Aitpillah F, Dedey F, Oppong J, Osei-Bonsu EB, Duggan MA, ... ... Luccarini C, et al. Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35654374 DOI: 10.1158/1055-9965.EPI-21-1397 |
0.443 |
|
2022 |
Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, González-Neira A, Heijl SM, Adank MA, Ahearn TU, Andrulis IL, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, ... ... Luccarini C, et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Medicine. 14: 51. PMID 35585550 DOI: 10.1186/s13073-022-01052-8 |
0.6 |
|
2022 |
Schack LMH, Naderi E, Fachal L, Dorling L, Luccarini C, Dunning AM, Ong EHW, Chua MLK, Langendijk JA, Alizadeh BZ, Overgaard J, Eriksen JG, Andreassen CN, Alsner J. A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis. British Journal of Cancer. PMID 35039627 DOI: 10.1038/s41416-021-01670-w |
0.341 |
|
2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, ... ... Luccarini C, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 2986. PMID 33990587 DOI: 10.1038/s41467-021-23162-4 |
0.468 |
|
2021 |
Ng PS, Boonen RA, Wijaya E, Chong CE, Sharma M, Knaup S, Mariapun S, Ho WK, Lim J, Yoon SY, Mohd Taib NA, See MH, Li J, Lim SH, Tan EY, ... ... Luccarini C, et al. Characterisation of protein-truncating and missense variants in in 15 768 women from Malaysia and Singapore. Journal of Medical Genetics. PMID 33811135 DOI: 10.1136/jmedgenet-2020-107471 |
0.457 |
|
2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, ... ... Luccarini C, et al. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 1078. PMID 33597508 DOI: 10.1038/s41467-020-20496-3 |
0.442 |
|
2021 |
Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine. PMID 33471991 DOI: 10.1056/NEJMoa1913948 |
0.559 |
|
2020 |
Gaba F, Blyuss O, Liu X, Goyal S, Lahoti N, Chandrasekaran D, Kurzer M, Kalsi J, Sanderson S, Lanceley A, Ahmed M, Side L, Gentry-Maharaj A, Wallis Y, Wallace A, ... ... Luccarini C, et al. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention. Cancers. 12. PMID 32429029 DOI: 10.3390/Cancers12051241 |
0.388 |
|
2019 |
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, et al. Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901907. PMID 31841383 DOI: 10.1200/Jco.19.01907 |
0.579 |
|
2019 |
Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Ahmed S, Baynes C, Conroy DM, Brown J, Luben R, Ostrander EA, Pharoah PDP, Dunning AM, et al. Targeted resequencing of the coding sequence of 38 genes near breast cancer GWAS loci in a large case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30642840 DOI: 10.1158/1055-9965.Epi-18-0298 |
0.632 |
|
2018 |
Li J, Ugalde-Morales E, Wen WX, Decker B, Eriksson M, Torstensson A, Christensen HN, Dunning AM, Allen J, Luccarini C, Pooley KA, Simard J, Dorling L, Easton DF, Teo SH, et al. Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. Cancer Research. 78: 6329-6338. PMID 30385609 DOI: 10.1158/0008-5472.Can-18-1018 |
0.606 |
|
2018 |
Li J, Wen WX, Eklund M, Kvist A, Eriksson M, Christensen HN, Torstensson A, Bajalica-Lagercrantz S, Dunning AM, Decker B, Allen J, Luccarini C, Pooley K, Simard J, Dorling L, et al. Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort. International Journal of Cancer. PMID 30175445 DOI: 10.1002/Ijc.31841 |
0.524 |
|
2018 |
Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, ... ... Luccarini C, et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics. PMID 29915430 DOI: 10.1038/S41588-018-0132-X |
0.628 |
|
2018 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Luccarini C, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 9: 16193. PMID 29633761 DOI: 10.1038/Ncomms16193 |
0.527 |
|
2018 |
Gao B, Lu Y, Nieuweboer AJM, Xu H, Beesley J, Boere I, de Graan AM, de Bruijn P, Gurney H, J Kennedy C, Chiew YE, Johnatty SE, Beale P, Harrison M, Luccarini C, et al. Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer. Scientific Reports. 8: 1508. PMID 29367611 DOI: 10.1038/S41598-018-19590-W |
0.5 |
|
2018 |
Schack LMH, Dorling L, Fachal L, Luccarini C, Dunning AM, Eriksen JG, Andreassen CN, Alsner J, Overgaard J. OC-0485: Genetic variants associated with radiation-induced morbidity in a head-and neck cancer cohort Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30795-3 |
0.393 |
|
2017 |
Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, ... ... Luccarini C, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. PMID 29059683 DOI: 10.1038/Nature24284 |
0.674 |
|
2017 |
Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Luccarini C, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785 |
0.642 |
|
2017 |
Wen WX, Allen J, Lai KN, Mariapun S, Hasan SN, Ng PS, Lee DS, Lee SY, Yoon SY, Lim J, Lau SY, Decker B, Pooley K, Dorling L, Luccarini C, et al. Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. Journal of Medical Genetics. PMID 28993434 DOI: 10.1136/Jmedgenet-2017-104947 |
0.547 |
|
2017 |
Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Ahmed S, Baynes C, Conroy DM, Brown J, Luben R, Ostrander EA, Pharoah PD, Dunning AM, et al. Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. Journal of Medical Genetics. PMID 28779002 DOI: 10.1136/Jmedgenet-2017-104588 |
0.626 |
|
2017 |
Eccles D, Copson E, Maishman T, Tapper W, Cutress R, Gerty S, Stanton L, Altman D, Durcan L, Simmonds P, Decker B, Allen J, Luccarini C, Easton D, Dunning A. Abstract S2-03: Does BRCA status affect outcome in young breast cancer patients? Results from the prospective study of outcomes in sporadic and hereditary breast cancer (POSH) Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-S2-03 |
0.547 |
|
2017 |
Wen WX, Lai KN, Allen J, Luccarini C, Mariapun S, Yip CH, Taib NAM, Dunning A, Easton D, Teo SH. Abstract 4288: Inherited mutations inBRCA1andBRCA2in an unselected multi-ethnic cohort of Asian breast cancer patients and healthy controls from Malaysia Epidemiology. 77: 4288-4288. DOI: 10.1158/1538-7445.Am2017-4288 |
0.526 |
|
2016 |
Amos CI, Dennis J, Wang Z, Byun J, Schumacher FR, Gayther SA, Casey G, Hunter DJ, Sellers TA, Gruber SB, Dunning AM, Michailidou K, Fachal L, Doheny K, Spurdle AB, ... ... Luccarini C, et al. The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27697780 DOI: 10.1158/1055-9965.Epi-16-0106 |
0.508 |
|
2016 |
Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Luccarini C, et al. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American Journal of Human Genetics. PMID 27640304 DOI: 10.1016/J.Ajhg.2016.07.017 |
0.67 |
|
2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Luccarini C, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.468 |
|
2016 |
Horne HN, Chung CC, Zhang H, Yu K, Prokunina-Olsson L, Michailidou K, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, Lophatananon A, ... ... Luccarini C, et al. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. Plos One. 11: e0160316. PMID 27556229 DOI: 10.1371/Journal.Pone.0160316 |
0.686 |
|
2016 |
Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics. PMID 26921362 DOI: 10.1136/Jmedgenet-2015-103529 |
0.585 |
|
2016 |
Decker B, Allen J, Luccarini C, Pooley KA, Pharoah PP, Dunning AM, Easton DF. Abstract 4309: Rare protein truncating and missense variants in ATM, CHEK2, PALB2, but not XRCC2, confer increased breast cancer risks Cancer Research. 76: 4309-4309. DOI: 10.1158/1538-7445.Am2016-4309 |
0.604 |
|
2015 |
Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, ... ... Luccarini C, et al. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute. 107. PMID 26296642 DOI: 10.1093/Jnci/Djv219 |
0.611 |
|
2015 |
Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, ... ... Luccarini C, et al. Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute. 107. PMID 25855707 DOI: 10.1093/Jnci/Djv036 |
0.617 |
|
2015 |
Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q, Shah M, Perkins BJ, Czene K, Eriksson M, Darabi H, Brand JS, ... ... Luccarini C, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics. 47: 373-80. PMID 25751625 DOI: 10.1038/Ng.3242 |
0.641 |
|
2015 |
Orr N, Dudbridge F, Dryden N, Maguire S, Novo D, Perrakis E, Johnson N, Ghoussaini M, Hopper JL, Southey MC, Apicella C, Stone J, Schmidt MK, Broeks A, Van't Veer LJ, ... ... Luccarini C, et al. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Human Molecular Genetics. 24: 2966-84. PMID 25652398 DOI: 10.1093/Hmg/Ddv035 |
0.634 |
|
2015 |
Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, Michailidou K, Bolla MK, Wang Q, Dennis J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, ... ... Luccarini C, et al. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis. 36: 256-71. PMID 25586992 DOI: 10.1093/Carcin/Bgu326 |
0.695 |
|
2015 |
Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM, Kaufmann S, Beesley J, Canisius S, Hopper JL, Southey MC, ... ... Luccarini C, et al. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. American Journal of Human Genetics. 96: 5-20. PMID 25529635 DOI: 10.1016/J.Ajhg.2014.11.009 |
0.659 |
|
2015 |
Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, Hopper JL, Apicella C, Southey MC, Stone J, Schmidt MK, Broeks A, Van't Veer LJ, Th Rutgers EJ, Muir K, Lophatananon A, ... ... Luccarini C, et al. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Human Molecular Genetics. 24: 285-98. PMID 25168388 DOI: 10.1093/Hmg/Ddu431 |
0.657 |
|
2015 |
Gao B, Lu Y, Nieuweboer AJM, Xu H, Beesley J, Boere I, Graan AMd, Bruijn Pd, Gurney H, Kennedy C, Chiew Y, Johnatty SE, Beale P, Harrison M, Luccarini C, et al. Abstract 5493: Genome-wide study of carboplatin and paclitaxel disposition in ovarian cancer patients Cancer Research. 75: 5493-5493. DOI: 10.1158/1538-7445.Am2015-5493 |
0.476 |
|
2014 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Luccarini C, et al. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 4: 4999. PMID 25248036 DOI: 10.1038/Ncomms5999 |
0.636 |
|
2014 |
Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP, Hopper JL, Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van't Veer LJ, ... ... Luccarini C, et al. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research : Bcr. 16: R51. PMID 24887515 DOI: 10.1186/Bcr3662 |
0.63 |
|
2014 |
Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, ... ... Luccarini C, et al. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 178-85. PMID 24785509 DOI: 10.1016/J.Radonc.2014.02.012 |
0.452 |
|
2013 |
French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, ... ... Luccarini C, et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. American Journal of Human Genetics. 92: 489-503. PMID 23540573 DOI: 10.1016/J.Ajhg.2013.01.002 |
0.554 |
|
2013 |
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russell R, Russel R, Dunning AM, Luccarini C, Dennis J, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Human Molecular Genetics. 22: 2520-8. PMID 23535824 DOI: 10.1093/Hmg/Ddt086 |
0.532 |
|
2013 |
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics. 45: 385-91, 391e1-2. PMID 23535732 DOI: 10.1038/Ng.2560 |
0.467 |
|
2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Luccarini C, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.626 |
|
2013 |
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, ... ... Luccarini C, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature Genetics. 45: 353-61, 361e1-2. PMID 23535729 DOI: 10.1038/Ng.2563 |
0.699 |
|
2012 |
Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo KY, Noh DY, Ahn SH, Dork T, Schürmann P, ... ... Luccarini C, et al. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. Plos One. 7: e35706. PMID 22768030 DOI: 10.1371/journal.pone.0035706 |
0.641 |
|
2012 |
Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics. 44: 312-8. PMID 22267197 DOI: 10.1038/Ng.1049 |
0.669 |
|
2012 |
Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, Wilkinson JS, Tyrer J, Misra V, Platte R, Gulliford SL, Sydes MR, Hall E, Bentzen SM, Dearnaley DP, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. The Lancet. Oncology. 13: 65-77. PMID 22169268 DOI: 10.1016/S1470-2045(11)70302-3 |
0.59 |
|
2012 |
Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo K, Noh D, Ahn S, Dörk T, Schürmann P, ... ... Luccarini C, et al. SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. Plos One. DOI: 10.1371/Journal.Pone.0035706.G002 |
0.42 |
|
2011 |
Scollen S, Luccarini C, Baynes C, Driver K, Humphreys MK, Garcia-Closas M, Figueroa J, Lissowska J, Pharoah PD, Easton DF, Hesketh R, Metcalfe JC, Dunning AM. TGF-β signaling pathway and breast cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1112-9. PMID 21527583 DOI: 10.1158/1055-9965.Epi-11-0062 |
0.626 |
|
2011 |
Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Earl HM, Dunning AM, Pharoah PD, Caldas C. CYP2D6 gene variants and their association with breast cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1255-8. PMID 21527579 DOI: 10.1158/1055-9965.Epi-11-0321 |
0.672 |
|
2010 |
Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Shah M, Ingle S, Greenberg D, Earl HM, Dunning AM, Pharoah PD, Caldas C. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen. Breast Cancer Research : Bcr. 12: R64. PMID 20731819 DOI: 10.1186/Bcr2629 |
0.602 |
|
2009 |
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, Neuhausen SL, Ding YC, Couch FJ, ... ... Luccarini C, et al. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer. 101: 2048-54. PMID 19920816 DOI: 10.1038/Sj.Bjc.6605416 |
0.661 |
|
2009 |
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, ... ... Luccarini C, et al. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 101: 1456-60. PMID 19707196 DOI: 10.1038/Sj.Bjc.6605279 |
0.629 |
|
2009 |
Field HI, Scollen SA, Luccarini C, Baynes C, Morrison J, Dunning AM, Easton DF, Pharoah PD. Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design. Bmc Bioinformatics. 10: 180. PMID 19523221 DOI: 10.1186/1471-2105-10-180 |
0.365 |
|
2006 |
Lesueur F, Song H, Ahmed S, Luccarini C, Jordan C, Luben R, Easton DF, Dunning AM, Pharoah PD, Ponder BA. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population. British Journal of Cancer. 94: 1921-6. PMID 16685266 DOI: 10.1038/Sj.Bjc.6603160 |
0.679 |
|
2006 |
Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Research. 66: 1225-33. PMID 16424062 DOI: 10.1158/0008-5472.Can-05-1857 |
0.664 |
|
2006 |
Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics. 15: 1-10. PMID 16306136 DOI: 10.1093/Hmg/Ddi398 |
0.653 |
|
2005 |
Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 90: 6268-74. PMID 16091499 DOI: 10.1210/Jc.2004-2449 |
0.39 |
|
2005 |
Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs. Bmc Cancer. 5: 81. PMID 16029503 DOI: 10.1186/1471-2407-5-81 |
0.666 |
|
2005 |
Benusiglio PR, Luccarini C, Ajai O, Ponder BA, Pharoah PD. Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant. Carcinogenesis. 26: 2213. PMID 16014700 DOI: 10.1093/Carcin/Bgi181 |
0.47 |
|
2005 |
Benusiglio PR, Lesueur F, Luccarini C, Conroy DM, Shah M, Easton DF, Day NE, Dunning AM, Pharoah PD, Ponder BA. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Research : Bcr. 7: R204-9. PMID 15743501 DOI: 10.1186/Bcr982 |
0.68 |
|
2005 |
Ponder B, Cebrian A, Dunning A, Easton D, Lesueur F, Luccarini C, Pharoah P. The search for low-penetrance breast cancer genes Breast Cancer Research. 7: 1-1. DOI: 10.1186/Bcr1083 |
0.555 |
|
Show low-probability matches. |